← Back to Search

Family Foundations Program for New Parents (FF2 Trial)

N/A
Waitlist Available
Research Sponsored by Penn State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2.5 years from baseline
Awards & highlights

FF2 Trial Summary

This trial will test whether the Family Foundations program is effective in helping families cope with a new baby.

Who is the study for?
This trial is for couples who are expecting their first child, living together, and planning to raise the child jointly. Both partners must be at least 18 years old.Check my eligibility
What is being tested?
The study is testing the Family Foundations program's effectiveness in helping families adjust to having a new baby and improving parent-child relationships.See study design
What are the potential side effects?
Since this trial involves a family support program rather than medical or pharmaceutical interventions, there are no direct physical side effects. However, participants may experience emotional or psychological responses.

FF2 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

FF2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2.5 years from baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2.5 years from baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Coparenting Quality
Secondary outcome measures
Aggressive Parenting
Other outcome measures
Cardiovascular disease risk

FF2 Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Couples randomly assigned to the Intervention Group received the Family Foundations Coparenting Program.
Group II: Control GroupActive Control1 Intervention
Couples in the Control group did not receive the Family Foundations Coparenting Program.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Family Foundations Coparenting Program
2002
N/A
~500

Find a Location

Who is running the clinical trial?

Penn State UniversityLead Sponsor
355 Previous Clinical Trials
124,557 Total Patients Enrolled

Media Library

Family Foundations Coparenting Program Clinical Trial Eligibility Overview. Trial Name: NCT01907412 — N/A
Parent-Child Relationship Research Study Groups: Control Group, Intervention Group
Parent-Child Relationship Clinical Trial 2023: Family Foundations Coparenting Program Highlights & Side Effects. Trial Name: NCT01907412 — N/A
Family Foundations Coparenting Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT01907412 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Maternal and Child Health JournalJournal
Preventive Effects on Birth Outcomes: Buffering Impact of Maternal Stress, Depression, and Anxiety
Feinberg, Mark E., Damon E. Jones, Michael E. Roettger, Michelle L. Hostetler, Kari-Lyn Sakuma, Ian M. Paul, and Deborah B. Ehrenthal. 2015. “Preventive Effects on Birth Outcomes: Buffering Impact of Maternal Stress, Depression, and Anxiety”. Maternal and Child Health Journal. Springer Science and Business Media LLC. doi:10.1007/s10995-015-1801-3.
clinicaltrials.govStudy
Trial of Transition to Parenthood Program for Couples
Mark Feinberg 2008. "Trial of Transition to Parenthood Program for Couples". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01907412.
~168 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top